Detection of P53 and Mdm2 in vitiligo

Detection of P53 and Mdm2 in vitiligo

Bibliographic Details
Main Author:	Viroj Wiwanitkit
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2013-01-01
Series:	Indian Dermatology Online Journal
Online Access:	http://www.idoj.in/article.asp?issn=2229-5178;year=2013;volume=4;issue=1;spage=61;epage=62;aulast=Wiwanitkit

Similar Items

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
by: Kelly M Thayer, et al.
Published: (2016-01-01)

Evolution of the p53-MDM2 pathway
by: Emma Åberg, et al.
Published: (2017-08-01)

MDM2 inhibitors: Targeting p53-MDM2 interaction to anti-cancer
by: Zhang Xulin
Published: (2021-01-01)

The dual interactions of p53 with MDM2 and p300 : implications for the design of MDM2 inhibitors
by: Kannan, Srinivasaraghavan, et al.
Published: (2020)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
by: Vera V. Grinkevich, et al.
Published: (2022-06-01)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01)

Controlling the Mdm2-Mdmx-p53 Circuit
by: David L. Waning, et al.
Published: (2010-05-01)

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
by: Bergamaschi, D, et al.
Published: (2005)

Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
by: Min Hu, et al.
Published: (2006-02-01)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53-MDM2 Pathway.
Published: (2006-01-01)

Modulators of the p53-MDM2 interaction : search for MDM2 interactors using structural guidance
by: Lin, Jianqing
Published: (2014)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
by: Venkatesh, Byrappa, et al.
Published: (2016)

MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
by: Pathum Sookaromdee, et al.
Published: (2019-08-01)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
by: Raymond S. Traweek, et al.
Published: (2022-11-01)

p53 and MDM2 protein expression in actinic cheilitis
by: Maria da Conceição Andrade de Freitas, et al.
Published: (2008-12-01)

Molecular mechanism of CCDC106 regulating the p53-Mdm2/MdmX signaling axis
by: Ting Zhou, et al.
Published: (2023-12-01)

p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
by: Robin Levy, et al.
Published: (2019-03-01)

Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
by: Hilary V Clegg, et al.
Published: (2012-01-01)

p53 ubiquitination by Mdm2: a never ending tail?
by: Coutts, A, et al.
Published: (2009)

Mdm2 targets the p53 transcription cofactor JMY for degradation.
by: Coutts, A, et al.
Published: (2007)

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
by: Yadahalli, Shilpa, et al.
Published: (2019)

A theoretical exploration of birhythmicity in the p53-Mdm2 network.
by: Wassim Abou-Jaoudé, et al.
Published: (2011-02-01)

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
by: Villuendas, R, et al.
Published: (1997)

Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2
by: Jesús García‐Cano, et al.
Published: (2020-01-01)

Dynamical analysis of a delayed p53 oscillator model with p53-Mdm2 positive feedback
by: Hongli Yang, et al.
Published: (2022-09-01)

Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
by: Yujun Zhao, et al.
Published: (2013-07-01)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
by: Haohao Zhu, et al.
Published: (2022-07-01)

MDM2 and MDMX bind and stabilize the p53-related protein p73
by: Ongkeko, W, et al.
Published: (1999)

Mdm2 inhibits the apoptotic function of p53 mainly by targeting it for degradation.
by: Yap, D, et al.
Published: (2000)

RB regulates the stability and the apoptotic function of p53 via MDM2.
by: Hsieh, J, et al.
Published: (1999)

Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms
by: Konstantinos Karakostis, et al.
Published: (2020-12-01)

8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction.
by: Mariell Pettersson, et al.
Published: (2015-01-01)

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists
by: Constantinos G. Neochoritis, et al.
Published: (2019-02-01)

Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network.
by: Lilyn Daftuar, et al.
Published: (2013-01-01)

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.
by: Arva, N, et al.
Published: (2005)

Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis
by: Chunwei W. Lai, et al.
Published: (2022-01-01)

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
by: Jing Zhao, et al.
Published: (2021-02-01)

Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4
by: Vaas S, et al.
Published: (2023-04-01)

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors
by: Immacolata Maietta, et al.
Published: (2022-12-01)

Immunohistochemical detection of P53 and MDM2 and its correlation with histological grading system in ovine pulmonary adenocarcinoma
by: Enas S. Mustafa, et al.
Published: (2021-07-01)